Related references
Note: Only part of the references are listed.The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing
Michael A. Gordon et al.
MOLECULAR CARCINOGENESIS (2019)
Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations
Andrea Pellagatti et al.
BLOOD (2018)
Structure of the human activated spliceosome in three conformational states
Xiaofeng Zhang et al.
CELL RESEARCH (2018)
The role of alternative splicing in cancer drug resistance
Zahava Siegfried et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability
Kenichi Iwai et al.
EMBO MOLECULAR MEDICINE (2018)
MALAT1 modulates the autophagy of retinoblastoma cell through miR-124-mediated stx17 regulation
Jun Huang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds
Constantin Cretu et al.
MOLECULAR CELL (2018)
The long tail of oncogenic drivers in prostate cancer
Joshua Armenia et al.
NATURE GENETICS (2018)
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
Michael Seiler et al.
NATURE MEDICINE (2018)
Global profiling of hnRNP A2/B1-RNA binding on chromatin highlights LncRNA interactions
Eric D. Nguyen et al.
RNA BIOLOGY (2018)
Systematic Analysis of Splice-Site-Creating Mutations in Cancer
Reyka G. Jayasinghe et al.
CELL REPORTS (2018)
Prespliceosome structure provides insights into spliceosome assembly and regulation
Clemens Plaschka et al.
NATURE (2018)
Alternative splicing in prostate cancer
Alec Paschalis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT
Samuel E. Harvey et al.
RNA (2018)
Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis
Simon Braun et al.
NATURE COMMUNICATIONS (2018)
The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
Yi-Tsung Yang et al.
BLOOD CANCER JOURNAL (2018)
Long noncoding RNA MALAT1 suppresses breast cancer metastasis
Jongchan Kim et al.
NATURE GENETICS (2018)
Molecular Pathways: Understanding and Targeting Mutant Spliceosomal Proteins
Akihide Yoshimi et al.
CLINICAL CANCER RESEARCH (2017)
Modulating splicing with small molecular inhibitors of the spliceosome
Kerstin A. Effenberger et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2017)
Cryo-EM structure of a human spliceosome activated for step 2 of splicing
Karl Bertram et al.
NATURE (2017)
Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status
Kenichi Suda et al.
PLOS ONE (2017)
Regulatory mechanisms of. long noncoding RNAs on gene expression in cancers
Weiliang Sun et al.
CANCER GENETICS (2017)
The Functional Impact of Alternative Splicing in Cancer
Hector Climente-Gonzalez et al.
CELL REPORTS (2017)
Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer
Hanna Kedzierska et al.
CANCER LETTERS (2017)
An Atomic Structure of the Human Spliceosome
Xiaofeng Zhang et al.
CELL (2017)
The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mc1-1
M. Larrayoz et al.
LEUKEMIA (2016)
Conformational dynamics of stem II of the U2 snRNA
Margaret L. Rodgers et al.
RNA (2016)
Long noncoding RNAs: Re-writing dogmas of RNA processing and stability
Jeremy E. Wilusz
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
The hnRNP family: insights into their role in health and disease
Thomas Geuens et al.
HUMAN GENETICS (2016)
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
Therapeutic targeting of splicing in cancer
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages
Kerstin A. Effenberger et al.
RNA (2016)
Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics
Jeffery Chakedis et al.
ONCOTARGET (2016)
RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge et al.
NATURE REVIEWS CANCER (2016)
Welcoming Treat: Astrocyte-Derived Exosomes Induce PTEN Suppression to Foster Brain Metastasis
Masa Aleckovic et al.
CANCER CELL (2015)
Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models
Yimin Hua et al.
GENES & DEVELOPMENT (2015)
Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B
Manoj K. Kashyap et al.
HAEMATOLOGICA (2015)
SRSF1-Regulated Alternative Splicing in Breast Cancer
Olga Anczukow et al.
MOLECULAR CELL (2015)
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Tiffany Y. -T. Hsu et al.
NATURE (2015)
Intron retention is a widespread mechanism of tumor-suppressor inactivation
Hyunchul Jung- et al.
NATURE GENETICS (2015)
RON alternative splicing regulation in primary ovarian cancer
Sebastian Mayer et al.
ONCOLOGY REPORTS (2015)
Inhibitors of CLK Protein Kinases Suppress Cell Growth and Induce Apoptosis by Modulating Pre-mRNA Splicing
Shinsuke Araki et al.
PLOS ONE (2015)
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
Vikas Madan et al.
NATURE COMMUNICATIONS (2015)
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
Elena Sotillo et al.
CANCER DISCOVERY (2015)
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia
Silvia Xargay-Torrent et al.
ONCOTARGET (2015)
The network organization of protein interactions in the spliceosome is reproduced by the simple rules of food-web models
Mathias M. Pires et al.
SCIENTIFIC REPORTS (2015)
A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition
Jerneja Tomsic et al.
SCIENTIFIC REPORTS (2015)
Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
Rachel B. Darman et al.
CELL REPORTS (2015)
Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3′ Splice Site Selection in SF3B1-mutated Cancers
Christopher DeBoever et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B
Manoj K. Kashyap et al.
HAEMATOLOGICA (2015)
U2AF1 mutations alter splice site recognition in hematological malignancies
Janine O. Ilagan et al.
GENOME RESEARCH (2015)
SF3B1 mutations constitute a novel therapeutic target in breast cancer
Sarah L. Maguire et al.
JOURNAL OF PATHOLOGY (2015)
PRPF8 defects cause missplicing in myeloid malignancies
A. Kurtovic-Kozaric et al.
LEUKEMIA (2015)
Alternative splicing in cancer: implications for biology and therapy
J. Chen et al.
ONCOGENE (2015)
Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome
Diego M. Marzese et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)
Raoni Pais Siqueira et al.
PLOS ONE (2015)
Pre-mRNA Splicing-Modulatory Pharmacophores: The Total Synthesis of Herboxidiene, a Pladienolide-Herboxidiene Hybrid Analog and Related Derivatives
Chandraiah Lagisetti et al.
ACS CHEMICAL BIOLOGY (2014)
Long non-coding RNA HOTAIR in carcinogenesis and metastasis
Jinsong Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2014)
The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth
Hu Zhu et al.
CANCER LETTERS (2014)
Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
Fran Supek et al.
CELL (2014)
An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth
Adam S. Adler et al.
GENES & DEVELOPMENT (2014)
Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing
Yilin Xu et al.
GENES & DEVELOPMENT (2014)
Prognostic significance of bone invasion for oral cavity squamous cell carcinoma considered T1/T2 by American Joint Committee on Cancer size criteria
David Fried et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
Identification of Small Molecule Inhibitors of Pre-mRNA Splicing
Andrea Pawellek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Context-dependent control of alternative splicing by RNA-binding proteins
Xiang-Dong Fu et al.
NATURE REVIEWS GENETICS (2014)
A day in the life of the spliceosome
A. Gregory Matera et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Structural requirement of Ntc77 for spliceosome activation and first catalytic step
Hsin-Chou Chen et al.
NUCLEIC ACIDS RESEARCH (2014)
Characterization of the RNA recognition mode of hnRNP G extends its role in SMN2 splicing regulation
Ahmed Moursy et al.
NUCLEIC ACIDS RESEARCH (2014)
Sudemycin E influences alternative splicing and changes chromatin modifications
Paolo Convertini et al.
NUCLEIC ACIDS RESEARCH (2014)
Hallmarks of alternative splicing in cancer
S. Oltean et al.
ONCOGENE (2014)
A Pan-Cancer Analysis of Transcriptome Changes Associated with Somatic Mutations in U2AF1 Reveals Commonly Altered Splicing Events
Angela N. Brooks et al.
PLOS ONE (2014)
The RNA-Binding Protein QKI Suppresses Cancer-Associated Aberrant Splicing
Feng-Yang Zong et al.
PLOS GENETICS (2014)
Long Non-Coding RNA NEAT1 Associates with SRp40 to Temporally Regulate PPARγ2 Splicing during Adipogenesis in 3T3-L1 Cells
Denise R. Cooper et al.
GENES (2014)
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms
Mario Cazzola et al.
BLOOD (2013)
Phase I Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors
Ferry A. L. M. Eskens et al.
CLINICAL CANCER RESEARCH (2013)
Isolation and characterization of spliceostatin B, a new analogue of FR901464, from Pseudomonas sp No. 2663
Xiangyang Liu et al.
JOURNAL OF ANTIBIOTICS (2013)
RBFOX2 Is an Important Regulator of Mesenchymal Tissue-Specific Splicing in both Normal and Cancer Tissues
Julian P. Venables et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
RBM5, 6, and 10 Differentially Regulate NUMB Alternative Splicing to Control Cancer Cell Proliferation
Elias G. Bechara et al.
MOLECULAR CELL (2013)
Competition between Pre-mRNAs for the Splicing Machinery Drives Global Regulation of Splicing
Elizabeth M. Munding et al.
MOLECULAR CELL (2013)
Genome-wide Analysis Reveals SR Protein Cooperation and Competition in Regulated Splicing
Shatakshi Pandit et al.
MOLECULAR CELL (2013)
Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3
Marcel Martin et al.
NATURE GENETICS (2013)
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
J. William Harbour et al.
NATURE GENETICS (2013)
Alternative splicing: a pivotal step between eukaryotic transcription and translation
Alberto R. Kornblihtt et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
A complex network of factors with overlapping affinities represses splicing through intronic elements
Yang Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer
K. Kim et al.
ONCOGENE (2013)
On the classification of long non-coding RNAs
Lina Ma et al.
RNA BIOLOGY (2013)
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
Felicitas Thol et al.
BLOOD (2012)
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Manja Meggendorfer et al.
BLOOD (2012)
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes
Valeria Visconte et al.
BLOOD (2012)
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
Hideki Makishima et al.
BLOOD (2012)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
Snail Represses the Splicing Regulator Epithelial Splicing Regulatory Protein 1 to Promote Epithelial-Mesenchymal Transition
Lauren M. Reinke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Spliceosome and other novel mutations in chronic lymphocytic leukemia and myeloid malignancies
F. Damm et al.
LEUKEMIA (2012)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens et al.
NATURE (2012)
Whole-genome analysis informs breast cancer response to aromatase inhibition
Matthew J. Ellis et al.
NATURE (2012)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin et al.
NATURE (2012)
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Timothy A. Graubert et al.
NATURE GENETICS (2012)
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Victor Quesada et al.
NATURE GENETICS (2012)
The spliceosome as a target of novel antitumour drugs
Sophie Bonnal et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
Olga Anczukow et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Intronic splicing enhancers, cognate splicing factors and context-dependent regulation rules
Yang Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression
Y. Li et al.
ONCOGENE (2012)
A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma
Karin Wadt et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
Regulation of Mcl-1 by SRSF1 and SRSF5 in Cancer Cells
Hannah L. Gautrey et al.
PLOS ONE (2012)
Hallmarks of cancer: of all cancer cells, all the time?
Sebastien L. Floor et al.
TRENDS IN MOLECULAR MEDICINE (2012)
The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle
Shauna A. Henley et al.
CELL DIVISION (2012)
Oncogenic Splicing Factor SRSF1 Is a Critical Transcriptional Target of MYC
Shipra Das et al.
CELL REPORTS (2012)
Integrative Genome-wide Analysis Reveals Cooperative Regulation of Alternative Splicing by hnRNP Proteins
Stephanie C. Huelga et al.
CELL REPORTS (2012)
Cancer stem cells: an evolving concept
Long V. Nguyen et al.
NATURE REVIEWS CANCER (2012)
Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene Splicing
Liying Fan et al.
ACS CHEMICAL BIOLOGY (2011)
Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status
Xiang Guo et al.
BMC MEDICAL GENOMICS (2011)
c-Myc Regulates RNA Splicing of the A-Raf Kinase and Its Activation of the ERK Pathway
Jens Rauch et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Structural Requirements for the Antiproliferative Activity of Pre-mRNA Splicing Inhibitor FR901464
Sami Osman et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
Clare V. LeFave et al.
EMBO JOURNAL (2011)
Serine-arginine protein kinases: a small protein kinase family with a large cellular presence
Thomas Giannakouros et al.
FEBS JOURNAL (2011)
Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A
Anna Corrionero et al.
GENES & DEVELOPMENT (2011)
The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region
Eric G. Folco et al.
GENES & DEVELOPMENT (2011)
SR Proteins Induce Alternative Exon Skipping through Their Activities on the Flanking Constitutive Exons
Joonhee Han et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
The t(11;19)(q23;p13) fusing MLL with MYO1F is recurrent in infant acute myeloid leukemias
Francois P. Duhoux et al.
LEUKEMIA RESEARCH (2011)
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I. Poulikakos et al.
NATURE (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E. Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Lili Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Spliceosome Structure and Function
Cindy L. Will et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
An EMT-Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype
Irina M. Shapiro et al.
PLOS GENETICS (2011)
Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues
Georgios Boukakis et al.
BMC CANCER (2010)
Identification of ASF/SF2 as a Critical, Allele-Specific Effector of the Cyclin D1b Oncogene
Nicholas A. Olshavsky et al.
CANCER RESEARCH (2010)
An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis
Michael J. Moore et al.
CELL (2010)
RBM5 as a Putative Tumor Suppressor Gene for Lung Cancer
Leslie C. Sutherland et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Invariant U2 snRNA Nucleotides Form a Stem Loop to Recognize the Intron Early in Splicing
Rhonda Perriman et al.
MOLECULAR CELL (2010)
The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylation
Vidisha Tripathi et al.
MOLECULAR CELL (2010)
Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies
H. Makishima et al.
LEUKEMIA (2010)
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst et al.
NATURE GENETICS (2010)
Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation
Gabriel A. Roybal et al.
NUCLEIC ACIDS RESEARCH (2010)
A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma
Jeran K. Stratford et al.
PLOS MEDICINE (2010)
The SR protein family of splicing factors: master regulators of gene expression
Jennifer C. Long et al.
BIOCHEMICAL JOURNAL (2009)
Identification and characterisation of a novel antisense non-coding RNA from the RBM5 gene locus
Nina D. Rintala-Maki et al.
GENE (2009)
Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts
Jeremy R. Sanford et al.
GENOME RESEARCH (2009)
Synthetic mRNA Splicing Modulator Compounds with in Vivo Antitumor Activity
Chandraiah Lagisetti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma
Jehad Abubaker et al.
JOURNAL OF PATHOLOGY (2009)
Cancer-associated regulation of alternative splicing
Julian P. Venables et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Apoptosis and cancer: the genesis of a research field
Thomas G. Cotter
NATURE REVIEWS CANCER (2009)
Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in Transgenic mice
Yimin Hua et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis
Jing Yang et al.
DEVELOPMENTAL CELL (2008)
Patterns of missplicling caused by RB1 gene mutations in patients with retinoblastoma and association with phenotypic expression
Katherine Zhang et al.
HUMAN MUTATION (2008)
The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1
Gracjan Michlewski et al.
MOLECULAR CELL (2008)
p53-repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation
Ran Brosh et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
Polypyrimidine tract binding protein controls the transition from exon definition to an intron defined spliceosome
Shalini Sharma et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5
Kazuo Fushimi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
Zefeng Wang et al.
RNA (2008)
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Yoshihiko Kotake et al.
NATURE CHEMICAL BIOLOGY (2007)
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
Daisuke Kaida et al.
NATURE CHEMICAL BIOLOGY (2007)
Correction: Discovery and analysis of evolutionarily conserved intronic splicing regulatory elements
Gene W. Yeo et al.
PLOS GENETICS (2007)
Discovery and analysis of evolutionarily conserved intronic splicing regulatory elements
Gene W. Yeo et al.
PLOS GENETICS (2007)
Molecular cloning of hMena (ENAH) and its splice variant hMena+11a:: Epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines
Francesca Di Modugno et al.
CANCER RESEARCH (2007)
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Rotem Karni et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Phosphorylation by SR kinases regulates the binding of PTB-associated splicing factor (PSF) to the pre-mRNA polypyrimidine tract
Ching-Jung Huang et al.
FEBS LETTERS (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
An RNA map predicting Nova-dependent splicing regulation
Jernej Ule et al.
NATURE (2006)
An exonic splicing silencer represses spliceosome assembly after ATP-dependent exon recognition
Amy E. House et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Angiogenesis in cancer
Naoyo Nishida et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2006)
RB and cell cycle progression
C. Giacinti et al.
ONCOGENE (2006)
Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma
GM Hayes et al.
CANCER RESEARCH (2006)
Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate pre-mRNA splicing
R Martinez-Contreras et al.
PLOS BIOLOGY (2006)
Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene
C Ghigna et al.
MOLECULAR CELL (2005)
Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals
JG Underwood et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors
LL Chen et al.
ONCOGENE (2005)
Identification and characterization of a novel gene Saf transcribed from the opposite strand of Fas
MD Yan et al.
HUMAN MOLECULAR GENETICS (2005)
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107 I.: Taxonomy, fermentation, isolation and screening
T Sakai et al.
JOURNAL OF ANTIBIOTICS (2004)
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107 III.: In vitro and In vivo antitumor activities
Y Mizui et al.
JOURNAL OF ANTIBIOTICS (2004)
Systematic identification and analysis of exonic splicing silencers
ZF Wang et al.
CELL (2004)
Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping
A Goyenvalle et al.
SCIENCE (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Manipulation of alternative splicing by a newly developed inhibitor of Clks
M Muraki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The Prp19p-associated complex in spliceosome activation
SP Chan et al.
SCIENCE (2003)
Pre-mRNA splicing: Awash in a sea of proteins
MS Jurica et al.
MOLECULAR CELL (2003)
A novel splicing regulator shares a nuclear import pathway with SR proteins
MC Lai et al.
EMBO JOURNAL (2003)
GEX1 compounds, novel antitumor antibiotics related to herboxidiene, produced by Streptomyces sp -: II.: The effects on cell cycle progression and gene expression
Y Sakai et al.
JOURNAL OF ANTIBIOTICS (2002)
Splicing factor SRP20 is a novel partner of BCL6 in a t(3;6)(q27;p21) translocation in transformed follicular lymphoma
WY Chen et al.
GENES CHROMOSOMES & CANCER (2001)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Modification of alternative splicing of Bcl-x Pre-mRNA in prostate and breast cancer cells - Analysis of apoptosis and cell death
DR Mercatante et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The Rb/E2F pathway and cancer
JR Nevins
HUMAN MOLECULAR GENETICS (2001)
Initial sequencing and analysis of the human genome
ES Lander et al.
NATURE (2001)
Multisite RNA binding and release of polypyrimidine tract binding protein during the regulation of c-src neural-specific splicing
MY Chou et al.
MOLECULAR CELL (2000)
The human homologue of the yeast splicing factor Prp6p contains multiple TPR elements and is stably associated with the U5 snRNP via protein-protein interactions.
EM Makarov et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Share Paper
